logo

TRoMbone is launched! The UK feasibility randomised trial Testing radical prostatectomy in men with prostate cancer and oligoMetastases to the bone has opened at Oxford University [...]
Chemotherapy comes alive for prostate cancer! Systemic therapy for metastatic prostate cancer has radically changed in the last 10 years with the introduction of several novel agen[...]
Every week the Editor-in-Chief selects the Article of the Week from the current issue of BJUI. The abstract is reproduced below and you can click on the button to read the full art[...]
This study from Kaag et al. [1] investigates predictors of renal functional decline after radical nephroureterectomy (RNU) in patients with upper tract urothelial carcinoma (UTUC).[...]
Every week the Editor-in-Chief selects the Article of the Week from the current issue of BJUI. The abstract is reproduced below and you can click on the button to read the full art[...]
In this paper, Bennett et al. [1] report the effects of an anti-androgen drug on autophagy and the subsequent impact on response to androgen-deprivation therapy alone or combined w[...]
        Does androgen-ablation therapy (AAT) associated autophagy have a pro-survival effect in LNCaP human prostate cancer cells? Haley L. Bennett, Jacqueline [...]
This is the first reported case of prolonged survival of metastatic disease in penile cancer in a patient treated using this chemotherapy regime. Authors: Nowicki, Stefan; Hendry, [...]
We report 3 patients with MUC of the upper urinary tract who were evaluated and treated at our center between 2009 and 2011. Authors: Xiao-hua Zhang1,Zhou-jun Shen1,Xiu-ling Wu2,Zh[...]